Bone grafts are made from one of four main sources: your own bone, donor human bone, animal bone, or synthetic materials engineered in a lab. The specific material a surgeon chooses depends on the size of the bone defect, where it is in your body, and how much structural support the area needs. Each source has a different composition, and each works slightly differently to help new bone grow.
How Bone Grafts Actually Work
Before diving into materials, it helps to understand the three ways a graft can stimulate bone healing. Some grafts act as a scaffold, meaning new bone tissue physically grows along the surface of the graft material, filling in gaps over time. Others contain proteins that can recruit nearby cells and trigger them to transform into bone-forming cells, even in tissue that wouldn’t normally produce bone. The most powerful grafts bring their own living bone cells to the site, giving the area an immediate head start on rebuilding.
No single material does all three equally well. Your own bone is the only graft source that reliably does all three, which is why surgeons still consider it the gold standard. Every other option involves trade-offs between effectiveness, availability, and convenience.
Autografts: Your Own Bone
An autograft is bone harvested from one part of your body and transplanted to another. The hip (specifically the iliac crest), chin, and back of the jaw are common donor sites. Because the tissue is yours, it contains living bone cells, natural growth-signaling proteins, and a mineral framework that new bone can grow along. There’s zero risk of immune rejection or disease transmission.
The downside is that harvesting the bone requires a second surgical site, which means additional pain, a longer procedure, and sometimes a hospital stay. The amount of bone available is also limited. For small defects, particularly in dental procedures, autografts work extremely well. For large reconstructions, surgeons often need to supplement with other materials. In studies tracking dental bone graft outcomes, autograft sites showed the highest success rate at 96.4%.
Allografts: Donor Human Bone
Allografts come from human donors, typically cadaveric bone processed and stored in tissue banks. The bone goes through extensive screening and sterilization to minimize the risk of disease transmission. One of the most common forms is demineralized bone matrix, where the mineral content has been chemically stripped away to expose the proteins embedded inside. Those proteins can signal your body’s cells to start forming new bone at the graft site.
Allografts come in several physical forms: chips, powder, gel, putty, or flexible strips, depending on the application. Cortical (hard outer layer) allografts provide rigid structural support and are commonly used in spinal procedures, where their resistance to compressive force lets them bear weight even before they’ve fully integrated. Demineralized bone matrix, by contrast, is a popular choice for filling bone defects and assisting spinal fusions because of its protein content.
Because allografts don’t contain living cells from the patient, they can’t generate bone on their own. They rely on your body’s cells to migrate into the graft and build new tissue. Graft success rates in dental applications run around 92%, slightly lower than autografts but still reliable for most situations.
Xenografts: Animal Bone
Xenografts are derived from animal species, most commonly cows (bovine bone), but also pigs, horses, coral, and even algae-based sources. The organic material, including cells, fats, and proteins that could trigger an immune reaction, is removed through chemical and heat processing. What remains is primarily the mineral scaffold: a porous structure made of the same calcium phosphate minerals found in human bone.
Modern processing techniques, including supercritical CO2 treatment, can clean the bone matrix while preserving its natural mineral and collagen structure. These methods specifically eliminate the molecular markers responsible for cross-species immune reactions. The result is a biocompatible scaffold that your body’s bone cells can grow into over time, though it lacks the signaling proteins that actively recruit new bone formation.
Xenografts are widely available and don’t require a human donor, making them a practical choice for many dental and orthopedic procedures. Bovine-derived products like Bio-Oss are among the most commonly used bone grafts worldwide. In dental studies, xenograft sites showed about 91% graft success and 95.5% implant survival.
Synthetic Bone Grafts
Synthetic grafts are manufactured entirely in a lab, removing any biological source from the equation. The most widely used synthetic materials are calcium phosphate ceramics, which mimic the mineral component of natural bone. Two forms dominate the market:
- Hydroxyapatite has the chemical formula Ca₁₀(PO₄)₆(OH)₂, which is nearly identical to the mineral that makes up about 65% of your natural bone. Synthetic versions are manufactured as porous blocks or granules with porosity around 80%, giving bone cells plenty of surface area to grow into.
- Tricalcium phosphate (TCP) is another calcium phosphate ceramic that your body gradually absorbs and replaces with natural bone. It’s often combined with hydroxyapatite in “biphasic” products that balance long-term stability with controlled resorption.
Beyond ceramics, synthetic options include bioactive glasses (silica-based materials that bond chemically to bone), calcium sulfate, and various polymers. These materials all serve as scaffolds for bone growth but don’t actively signal your body to produce new bone cells. They’re available in abundance, carry no risk of disease transmission, and can be engineered to specific shapes and porosities. The trade-off is that they generally work best in smaller defects where your body’s own healing capacity can do the heavy lifting.
Growth Factor Additives
Some modern bone grafts include lab-made versions of the proteins your body naturally uses to trigger bone formation. The most prominent is a growth factor called BMP-2, first identified in the 1960s when researchers discovered that a protein extracted from bone matrix could induce bone growth even in soft tissue like muscle.
A synthetic version was approved for spinal fusion procedures in 2002, and its use grew rapidly, reaching 25% of all primary spine fusions and 40% of revision spine fusions in the U.S. by 2006. The protein is typically soaked into a collagen sponge carrier and placed at the fusion site, where it recruits cells and directs them to form new bone. It’s used as an alternative to harvesting the patient’s own bone, eliminating the need for a second surgical site.
These growth factor products do carry risks tied to inflammation. The same protein that stimulates bone formation also triggers inflammatory responses that can cause swelling and nerve irritation, particularly at higher doses. Surgeons weigh these risks against the benefits of avoiding a donor site harvest.
What Form the Graft Takes
Regardless of the source material, bone grafts are manufactured in different physical forms to match the surgical need. Particulate grafts (granules, chips, or powder) are packed into bone defects and work well for filling irregular spaces, like a tooth socket after an extraction. Block grafts are solid pieces of bone used when structural support is needed, such as rebuilding a section of jawbone before placing a dental implant. Putty and gel forms mix graft particles with a carrier material, making them easier to mold into place during surgery.
For spinal procedures, grafts often need to bear weight immediately. Cortical bone allografts or solid synthetic blocks are preferred in these cases because they resist compression while the fusion slowly incorporates. In dental applications, particulate grafts are far more common, packed into small defects where they’ll integrate over a healing period of four to six months before an implant is placed.
How Materials Compare in Practice
A retrospective study of 112 dental graft sites found an overall integration success rate of 92.8% across all graft types. Autografts led at 96.4%, followed by allografts at 92.3% and xenografts at 91.1%. These differences are relatively small, which is why the choice often comes down to practical factors: how much bone is needed, whether a second surgical site is acceptable, patient health, and cost.
For large or complex reconstructions, surgeons frequently combine materials. A common approach pairs autograft bone (for its living cells and growth signals) with an allograft or synthetic scaffold (for added volume). This stretches a limited supply of the patient’s own bone while still delivering the biological signals needed for robust healing.